[Efficacy and tolerance of a new sustained-release preparation of nicotinic alcohol for reduction of the atherosclerotic risk index].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000517:prevention & control*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D006951:Hyperlipoproteinemias / Q000150:complications / Q000188:drug therapy*; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009540:Nicotinyl Alcohol / Q000008:administration & dosage / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D012306:Risk
D003692:Delayed-Action Preparations; D011725:Pyridines; D009540:Nicotinyl Alcohol
Efficacia e tollerabilità di una nuova formulazione ritardo dell'alcool nicotinilico nel ridurre l'indice di rischio aterosclerotico.